| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/26/2006 | WO2006053439A1 Hcv f protein and uses thereof |
| 05/26/2006 | WO2006037070A3 Stabilization of alum-adjuvanted immunologically active agents |
| 05/26/2006 | WO2006036213A3 The use of gammaglobulin for the treatment of periodontal disease |
| 05/26/2006 | WO2006030318A3 PROTECTIVE ANTI-GLUCAN ANTIBODIES WITH PREFERENCE FOR β-1,3-GLUCANS |
| 05/26/2006 | WO2006018736A3 Use of golden hamster as infectivity model of sars |
| 05/26/2006 | WO2006004588A3 Immunodynamic complexes and methods for using and preparing such complexes |
| 05/26/2006 | WO2005120557A3 Inhibition of macrophage-stimulating protein receptor (ron) |
| 05/26/2006 | WO2005115452A3 Fcϝriib-specific antibodies and methods of use thereof |
| 05/26/2006 | WO2005111066A3 Polypeptides from non-typeable haemophilus influenzae |
| 05/26/2006 | WO2005104785A3 Methods and compositions for specifically targeting human hepatocellular carcinoma cells |
| 05/26/2006 | WO2005084306A3 Immunogenic compositions for chlamydia pneunomiae |
| 05/26/2006 | WO2005074633A3 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 05/26/2006 | WO2005028021A3 Methods for protection from toxicity of alpha emitting elements during radioimmunotherapy |
| 05/26/2006 | WO2004084835A3 Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor |
| 05/26/2006 | WO2004056316A3 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 05/26/2006 | WO2003100007A3 Eta-1 gene and methods for use |
| 05/26/2006 | CA2790433A1 Anti-addl antibodies and uses thereof |
| 05/26/2006 | CA2590671A1 Antibodies against vascular endothelial growth factor receptor-1 |
| 05/26/2006 | CA2588157A1 Cancer immunotherapy incorporating p53 |
| 05/26/2006 | CA2588066A1 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 05/26/2006 | CA2587903A1 Fully human monoclonal antibodies to il-13 |
| 05/26/2006 | CA2587849A1 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 05/26/2006 | CA2587716A1 Hcv f protein and uses thereof |
| 05/26/2006 | CA2587627A1 Desacyl ghrelin antibodies and therapeutic uses thereof |
| 05/26/2006 | CA2587597A1 Treatment for inflammatory bowel disorder |
| 05/26/2006 | CA2587001A1 Iontophoretic device and method for administering immune response-enhancing agents and compositions |
| 05/26/2006 | CA2586620A1 Multivalent vaccines comprising recombinant viral vectors |
| 05/26/2006 | CA2585549A1 Novel type leptin receptor antagonist |
| 05/26/2006 | CA2584859A1 Anti-addl antibodies and uses thereof |
| 05/26/2006 | CA2584222A1 Neutralising antibody molecules having specificity for human il-17 |
| 05/25/2006 | WO2006037038A9 Optimized vaccines to provide protection against ebola and other viruses |
| 05/25/2006 | WO2005111622A9 Diagnostic assay for trypanosoma cruzi infection |
| 05/25/2006 | US20060112437 Transgenic animal expressing alzheimer's tau protein |
| 05/25/2006 | US20060111561 Novel proteins and nucleic acids encoded thereby |
| 05/25/2006 | US20060111558 Recombinant infectious laryngotracheitis virus and uses thereof |
| 05/25/2006 | US20060111557 Water soluble toxin produced by pfiesteria species |
| 05/25/2006 | US20060111556 Preventives/remedies for neurodegenerative diseases |
| 05/25/2006 | US20060111551 Peptide having HTLV-1-specific CTL-inducing activity |
| 05/25/2006 | US20060111316 Treatment of inflammatory, non-infectious, autoimmune, vasculitic, degenerative vascular, host-v-graft diseases, Alzheimers disease, and amyloidosis using mammalian, dsDNA vaccination |
| 05/25/2006 | US20060111314 Method for treating or preventing metastasis of colorectal cancers |
| 05/25/2006 | US20060111293 Antagonists for human prolactin |
| 05/25/2006 | US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 05/25/2006 | US20060110803 Antigenic peptides of SARS coronavirus and uses thereof |
| 05/25/2006 | US20060110776 Monoclonal antibodies for binding to native proBNP to diagnose heart failure and hybridomas to produce antibodies |
| 05/25/2006 | US20060110775 Monoclonal antibodies for binding to native proBNP to diagnose heart failure and hybridomas to produce antibodies |
| 05/25/2006 | US20060110740 Use of sendai virus as a human parainfluenza vaccine |
| 05/25/2006 | US20060110736 Hiv vaccine formulations |
| 05/25/2006 | US20060110731 Cancer-linked gene as target for chemotherapy |
| 05/25/2006 | US20060110435 Allergy vaccine composition, production method thereof and use of same in allergy treatment |
| 05/25/2006 | US20060110429 Implant for intraocular drug delivery |
| 05/25/2006 | US20060110412 Vaccine composition |
| 05/25/2006 | US20060110411 Streptococcus equi vaccine compositions and method of use |
| 05/25/2006 | US20060110410 Recombinant toxin fragments |
| 05/25/2006 | US20060110409 Targeted agents for nerve regeneration |
| 05/25/2006 | US20060110408 Immunological combination compositions and methods |
| 05/25/2006 | US20060110407 Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection |
| 05/25/2006 | US20060110406 Refrigerator-temperature stable influenza vaccine compositions |
| 05/25/2006 | US20060110405 Plasma or serum fraction for treatment and prevention of viral infections and related conditions |
| 05/25/2006 | US20060110404 Set of ubiquitous cellular proteins involved in viral life cycle |
| 05/25/2006 | US20060110403 Non-human herpesviruses as vectors |
| 05/25/2006 | US20060110401 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 05/25/2006 | US20060110400 Immunogenic conjugates |
| 05/25/2006 | US20060110399 The solvent-detergent (S/D) process is used to inactivate enveloped viruses in plasma products; effectiveness of S/D treatment after fractionation and nanofiltration of an immune gamma globulin preparation |
| 05/25/2006 | US20060110398 DAP-10 and uses thereof |
| 05/25/2006 | US20060110397 Protein of given amino acid sequence; yeast-two-hybrid assay screening for agent which inhibits formation of heterodimer and gene expression; diagnosis and treatment of cancer |
| 05/25/2006 | US20060110396 Use of ligands of the antigen CDw52 for the treatment of diseases that are related to degenerated macrophages |
| 05/25/2006 | US20060110395 Use of CRKD as a breast cancer marker and cancer therapy target |
| 05/25/2006 | US20060110394 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury |
| 05/25/2006 | US20060110393 Novel proteins and use thereof |
| 05/25/2006 | US20060110392 Murine monoclonal antibody (5c8) recognizes T-B cell activating molecule (T-BAM) (CD40 LIGAND) on the surface of T-lymphocytes, compositions containing same and methods of use |
| 05/25/2006 | US20060110391 Compositions and methods for the treatment of body weight disorders, including obesity |
| 05/25/2006 | US20060110390 Inhibition of Ku as a treatment for cardiovascular diseases |
| 05/25/2006 | US20060110389 Method of treatment using anti-IL-18 antibody |
| 05/25/2006 | US20060110388 ß binding molecules |
| 05/25/2006 | US20060110387 Method for treating vasculitis |
| 05/25/2006 | US20060110386 Monoclonal antibody or an antigen binding fragment thereof which binds with selectivity to a human IL-B50 receptor complex comprising a human IL7R alpha subunit |
| 05/25/2006 | US20060110385 Means and methods for diagnosing and treating affective disorders |
| 05/25/2006 | US20060110384 Novel proteins and use thereof |
| 05/25/2006 | US20060110383 carcinoma; parenterally administering human anti-PD-1 antibody in which PD-L1 or PD-L2 is over-expressed postoperatively |
| 05/25/2006 | US20060110382 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis |
| 05/25/2006 | US20060110367 Compositions and methods for inhibiting pathogenic growth |
| 05/25/2006 | US20060110365 Novel bacterium for treatment of disease |
| 05/25/2006 | US20060110324 Human anti-epidermal growth factor receptor single-chain antibodies |
| 05/24/2006 | EP1659179A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659178A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659133A2 Human-murine chimeric antibodies against respiratory syncytial virus |
| 05/24/2006 | EP1659131A2 Polypeptides and nucleic acids encoding the same |
| 05/24/2006 | EP1658859A1 APO-2L receptor agonist and CPT-11 synergism |
| 05/24/2006 | EP1658772A2 Receptor specific transepithelial transport of immunogens |
| 05/24/2006 | EP1658370A1 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof |
| 05/24/2006 | EP1658311A2 Enhancing the circulating half-life of interleukin-2 proteins |
| 05/24/2006 | EP1658307A2 Methods for the early diagnosis of ovarian cancer |
| 05/24/2006 | EP1658097A1 Nucleotide and cellular vaccine composition |
| 05/24/2006 | EP1658096A1 Method of inducing immune tolerance |
| 05/24/2006 | EP1658078A2 Methods for intradermal delivery of therapeutics agents |
| 05/24/2006 | EP1658075A2 Composition and method for the treatment of cancer and other physiologic conditions based on modulation of the ppar-gamma pathway and her-kinase axis |
| 05/24/2006 | EP1658037A2 Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor |
| 05/24/2006 | EP1658036A2 Estrogen receptor modulators and uses thereof |
| 05/24/2006 | EP1423418B1 Mutated env gene, mutated env glycoprotein and the use thereof |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |